Suppr超能文献

癌相关成纤维细胞外泌体中的miR-21-5p抑制骨肉瘤中的铁死亡,并促进其增殖和迁移。

CAFs exosomal miR-21-5p suppresses ferroptosis and promotes proliferation and migration in osteosarcoma.

作者信息

Niu Xiaoying, Tian Wen, Ke Yuanmeng, Li Yifan, Zhang Xinxin

机构信息

The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.

The School of Public Health, Zhengzhou University, Henan, 450001, China.

出版信息

Cancer Cell Int. 2025 Aug 19;25(1):308. doi: 10.1186/s12935-025-03930-8.

Abstract

BACKGROUND

Osteosarcoma is one of the malignant tumors in children and adolescents patients. Uncontrolled and unlimited proliferation and metastasis lead to poor overall survival. CAFs play a pivotal role in the osteosarcoma tumor microenvironment, exerting significant influence on prognosis and treatment outcomes. However, there remains a need for further exploration into the intricate molecular mechanisms underlying CAFs.

METHODS

Single-cell RNA sequencing was employed to characterize the microenvironment of osteosarcoma. Tissue exosomal miRNA sequencing was conducted on tumor tissues and adjacent normal tissues to screen for abnormal expression of exosomal miRNAs. WGCNA analysis was used to identify target exosomal miRNAs. The relative expression of miR-21-5p was analyzed using qRT-PCR. The proliferation rate and migration ability of tumor cells were assessed using the CCK8 and Transwell method, respectively. Exosomes derived from cells were extracted and characterized via transmission electron microscopy and NTA analysis. siRNA interference was utilized to disrupt the expression of miR-21-5p in CAFs. Experiments in vivo validated the role of exosomal miR-21-5p in promoting malignant characteristics in osteosarcoma.

RESULTS

Single-cell RNA sequencing analysis of GSE162454 revealed the crucial role of CAFs in the pathogenesis of osteosarcoma. Tissue exosomal miRNA sequencing unveiled significant differential expression of miR-21-5p. Subsequently, aberrant upregulation of exosomal miR-21-5p exhibited a strong correlation with advanced clinical stage and poor prognosis in osteosarcoma. Further experiments in vitro indicated that elevated levels of miR-21-5p significantly enhanced proliferation and migration of osteosarcoma cells by suppressing ferroptosis. Moreover, experiments in vivo validated the capacity of CAFs-derived exosomal miR-21-5p to promote tumor growth and weight, thereby demonstrating their ability to deliver miR-21-5p to osteosarcoma cells and induce proliferation and migration through inhibition of ferroptosis.

CONCLUSIONS

Our findings indicate that exosomal miR-21-5p could potentially serve as a therapeutic target in osteosarcoma, providing initial evidence for further clinical investigation.

摘要

背景

骨肉瘤是儿童和青少年患者中的恶性肿瘤之一。不受控制的无限增殖和转移导致总体生存率低下。癌相关成纤维细胞(CAFs)在骨肉瘤肿瘤微环境中起关键作用,对预后和治疗结果有重大影响。然而,仍需要进一步探索CAFs背后复杂的分子机制。

方法

采用单细胞RNA测序来表征骨肉瘤的微环境。对肿瘤组织和相邻正常组织进行组织外泌体miRNA测序,以筛选外泌体miRNA的异常表达。利用加权基因共表达网络分析(WGCNA)来鉴定靶向外泌体miRNA。使用qRT-PCR分析miR-21-5p的相对表达。分别使用CCK8和Transwell方法评估肿瘤细胞的增殖率和迁移能力。通过透射电子显微镜和纳米颗粒跟踪分析(NTA)对细胞来源的外泌体进行提取和表征。利用小干扰RNA(siRNA)干扰来破坏CAFs中miR-21-5p的表达。体内实验验证了外泌体miR-21-5p在促进骨肉瘤恶性特征方面的作用。

结果

对GSE162454进行单细胞RNA测序分析揭示了CAFs在骨肉瘤发病机制中的关键作用。组织外泌体miRNA测序揭示了miR-21-5p的显著差异表达。随后,外泌体miR-21-5p的异常上调与骨肉瘤的晚期临床分期和不良预后密切相关。进一步的体外实验表明,miR-21-5p水平升高通过抑制铁死亡显著增强了骨肉瘤细胞的增殖和迁移。此外,体内实验验证了CAFs来源的外泌体miR-21-5p促进肿瘤生长和重量增加的能力,从而证明它们能够将miR-21-5p传递给骨肉瘤细胞并通过抑制铁死亡诱导增殖和迁移。

结论

我们的研究结果表明,外泌体miR-21-5p可能是骨肉瘤的一个治疗靶点,为进一步的临床研究提供了初步证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a79/12362868/a7646fb2e537/12935_2025_3930_Fig1_HTML.jpg

相似文献

1
CAFs exosomal miR-21-5p suppresses ferroptosis and promotes proliferation and migration in osteosarcoma.
Cancer Cell Int. 2025 Aug 19;25(1):308. doi: 10.1186/s12935-025-03930-8.
2
Rab27aCAF exosomal miR-9-5p promotes osteosarcoma progression via CREBRF/MAPK signaling pathway.
Cell Signal. 2025 Oct;134:111964. doi: 10.1016/j.cellsig.2025.111964. Epub 2025 Jun 26.
3
Identification of miRNA signature in cancer-associated fibroblast to predict recurrent prostate cancer.
Comput Biol Med. 2024 Sep;180:108989. doi: 10.1016/j.compbiomed.2024.108989. Epub 2024 Aug 13.
6
MiR-150-5p inhibits cell proliferation and metastasis by targeting FTO in osteosarcoma.
Oncol Res. 2024 Oct 16;32(11):1777-1789. doi: 10.32604/or.2024.047704. eCollection 2024.
8
New mechanism of miR-34a-5p in regulating the biological behavior of osteosarcoma by targeting FoxM1.
Cytotechnology. 2025 Jun;77(3):90. doi: 10.1007/s10616-025-00758-y. Epub 2025 Apr 21.

本文引用的文献

1
Flashback Foreword: Prognostic Factors in Osteosarcoma.
J Clin Oncol. 2023 Sep 20;41(27):4321-4322. doi: 10.1200/JCO.22.02860.
2
Activated fibroblasts in cancer: Perspectives and challenges.
Cancer Cell. 2023 Mar 13;41(3):434-449. doi: 10.1016/j.ccell.2023.02.015.
3
Overcoming cancer chemotherapy resistance by the induction of ferroptosis.
Drug Resist Updat. 2023 Jan;66:100916. doi: 10.1016/j.drup.2022.100916. Epub 2022 Dec 29.
4
New Horizons in the Treatment of Osteosarcoma.
N Engl J Med. 2021 Nov 25;385(22):2066-2076. doi: 10.1056/NEJMra2103423.
7
Fibroblasts as immune regulators in infection, inflammation and cancer.
Nat Rev Immunol. 2021 Nov;21(11):704-717. doi: 10.1038/s41577-021-00540-z. Epub 2021 Apr 28.
8
Novel approaches to target the microenvironment of bone metastasis.
Nat Rev Clin Oncol. 2021 Aug;18(8):488-505. doi: 10.1038/s41571-021-00499-9. Epub 2021 Apr 19.
9
Biology and pathogenesis of human osteosarcoma.
Oncol Lett. 2020 Feb;19(2):1099-1116. doi: 10.3892/ol.2019.11229. Epub 2019 Dec 18.
10
Tumor microenvironment targeted nanotherapeutics for cancer therapy and diagnosis: A review.
Acta Biomater. 2020 Jan 1;101:43-68. doi: 10.1016/j.actbio.2019.09.009. Epub 2019 Sep 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验